Burch L - Search Results

1

131I-3F8: clinical validation of imaging studies and therapeutic applications.

Cheung NK, Yeh SD, Gulati S, LaQuaglia M, Burch L, Kushner BH, Larson S. Cheung NK, et al. Among authors: burch l. Prog Clin Biol Res. 1991;366:409-15. Prog Clin Biol Res. 1991. PMID: 2068155 No abstract available.

2

Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.

Yeh SD, Larson SM, Burch L, Kushner BH, Laquaglia M, Finn R, Cheung NK. Yeh SD, et al. Among authors: burch l. J Nucl Med. 1991 May;32(5):769-76. J Nucl Med. 1991. PMID: 1902508 Free article.

3

Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.

Cheung NK, Burch L, Kushner BH, Munn DH. Cheung NK, et al. Among authors: burch l. Prog Clin Biol Res. 1991;366:395-400. Prog Clin Biol Res. 1991. PMID: 2068154 Clinical Trial. No abstract available.

4

Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.

Cheung NK, Heller G, Kushner BH, Burch L, O'Reilly RJ. Cheung NK, et al. Among authors: burch l. Prog Clin Biol Res. 1991;366:567-73. Prog Clin Biol Res. 1991. PMID: 2068175 No abstract available.

5

The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.

Shimizu H, Burch LR, Smith AJ, Dornan D, Wallace M, Ball KL, Hupp TR. Shimizu H, et al. Among authors: burch lr. J Biol Chem. 2002 Aug 9;277(32):28446-58. doi: 10.1074/jbc.M202296200. Epub 2002 Mar 29. J Biol Chem. 2002. PMID: 11925449 Free article.

6

Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.

Craig A, Scott M, Burch L, Smith G, Ball K, Hupp T. Craig A, et al. Among authors: burch l. EMBO Rep. 2003 Aug;4(8):787-92. doi: 10.1038/sj.embor.embor901. EMBO Rep. 2003. PMID: 12897801 Free PMC article.

7

The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Dornan D, Shimizu H, Burch L, Smith AJ, Hupp TR. Dornan D, et al. Among authors: burch l. Mol Cell Biol. 2003 Dec;23(23):8846-61. doi: 10.1128/MCB.23.23.8846-8861.2003. Mol Cell Biol. 2003. PMID: 14612423 Free PMC article.

8

Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.

Burch L, Shimizu H, Smith A, Patterson C, Hupp TR. Burch L, et al. J Mol Biol. 2004 Mar 12;337(1):129-45. doi: 10.1016/j.jmb.2004.01.017. J Mol Biol. 2004. PMID: 15001357

9

Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA.

Burch LR, Midgley CA, Currie RA, Lane DP, Hupp TR. Burch LR, et al. FEBS Lett. 2000 Apr 21;472(1):93-8. doi: 10.1016/s0014-5793(00)01427-7. FEBS Lett. 2000. PMID: 10781812 Free article.

10

DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing.

Harrison B, Kraus M, Burch L, Stevens C, Craig A, Gordon-Weeks P, Hupp TR. Harrison B, et al. Among authors: burch l. J Biol Chem. 2008 Apr 11;283(15):9999-10014. doi: 10.1074/jbc.M706040200. Epub 2008 Jan 14. J Biol Chem. 2008. PMID: 18195017 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters